Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

"Currently, Medicare covers these drugs only under specific circumstances, such as for diabetes or heightened heart risk," he wrote. "And Medicaid coverage is even more limited." Fetterman added ...

GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications in 2008, and 33% did by 2023 – an 800% increase. Some people with type 1 ...

(CNN) — The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on ...

Gymnema is a complementary treatment for type 1 and type 2 diabetes. While it isn’t a replacement for insulin, it may aid in blood sugar regulation. Gymnema is a woody climbing shrub from the ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take ...

Image credit: mbbirdy/Getty Images. A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes.

More information: Huilin Tang et al, GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias, JAMA Neurology (2025). DOI: 10.1001/jamaneurol.2025.0353 ...